Comments
Loading...

Cullinan Therapeutics (CGEM) Stock Price, Quote, News & History

CGEMNASDAQ
Logo brought to you by Benzinga Data
$8.35
0.557.05%
At close: Nov 12, 4:00 PM EST
$8.38
0.03000.36%
After Hours: 7:19 PM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Trends and Forecast

1
Jun
2
Aug
2
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
$7.80
Close
$8.35
Volume / Avg.
696.67K / 886.48K
Day Range
$7.72 - $8.49
52 Wk Range
5.68 - 17.50
Market Cap
$495.06M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
12.75%
Days to Cover
6

About

Sector
Health Care
Industry
Biotechnology
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. I...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CGEM
DRUG

FAQ

Q

How do I buy Cullinan Therapeutics (CGEM) stock?

A

You can purchase shares of Cullinan Therapeutics (NASDAQ:CGEM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cullinan Therapeutics (CGEM) competitors?

Q

What is the forecast, or price target, for Cullinan Therapeutics (CGEM) stock?

A

Cullinan Therapeutics has a consensus price target of $27.40.

Q

What is the current price for Cullinan Therapeutics (CGEM)?

A

The stock price for Cullinan Therapeutics (NASDAQ: CGEM) is $8.38 last updated November 12, 2025 at 7:19 PM EST.

Q

Does Cullinan Therapeutics (CGEM) pay a dividend?

A

There are no upcoming dividends for Cullinan Therapeutics.

Q

When is Cullinan Therapeutics (NASDAQ:CGEM) reporting earnings?

A

Cullinan Therapeutics’s Q3 earnings are confirmed for Thursday, November 6, 2025.

Q

Is Cullinan Therapeutics (CGEM) going to split?

A

There is no upcoming split for Cullinan Therapeutics.

Q

What sector and industry does Cullinan Therapeutics (CGEM) operate in?

A

Cullinan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch